Details of the Drug | DrugMAP

General Information of Drug (ID: DMKGSWM)

Drug Name

EB-1020

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C15H16ClN
Canonical SMILES: C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3.Cl
InChI: 1S/C15H15N.ClH/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15;/h1-7,14,16H,8-10H2;1H/t14-,15+;/m1./s1
InChIKey: ACVMJAJGCQUPKX-LIOBNPLQSA-N

Cross-matching ID

PubChem CID: 68943792
CAS Number: 923981-14-0
TTD ID: D03AYQ

References

1	ClinicalTrials.gov (NCT01939353) An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder. U.S. National Institutes of Health.